By CBJ
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (鈥淩akovina鈥 or the 鈥淐ompany鈥) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to highlight the strength and scientific leadership of its established Scientific Advisory Board (SAB). Rakovina鈥檚 SAB is composed of internationally […]